Repligen Corporation (RGEN)
NASDAQ: RGEN
· Real-Time Price · USD
113.52
-2.66 (-2.29%)
At close: Sep 04, 2025, 9:32 AM
-2.29% (1D)
| Bid | 113.18 |
| Market Cap | 6.39B |
| Revenue (ttm) | 673.96M |
| Net Income (ttm) | -13.83M |
| EPS (ttm) | -0.25 |
| PE Ratio (ttm) | -454.08 |
| Forward PE | 55.11 |
| Analyst | Buy |
| Ask | 114.2 |
| Volume | 16,601 |
| Avg. Volume (20D) | 797,311 |
| Open | 115.43 |
| Previous Close | 116.18 |
| Day's Range | 113.31 - 115.43 |
| 52-Week Range | 102.97 - 182.52 |
| Beta | 1.05 |
About RGEN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGEN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Repligen Corporation is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+4.72%
Repligen shares are trading higher after the compa...
Unlock content with
Pro Subscription
5 months ago
-5.54%
Repligen shares are trading lower. Evercore ISI Group initiated coverage on the stock with an In-Line rating.
2 months ago · businesswire.com
908 Devices Appoints Christopher D. Brown to its Board of DirectorsBOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, ...